Description
Made With Ingredients Based On The Landmark AREDS 2 Clinical Trial
*The Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial. JAMA. 2013
Lutein + Zeaxanthin & Omega-3 Fatty Acids Showed To Support:
-
25% Reduction In Risk Of Progression From Intermediate To Advanced AMD (Age-Related Macular Degeneration)
-
19% Reduction In Risk Of Central Vision Loss In AREDS Study Participants